Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,399 | -124,088 | -162,808 | -110,996 | -57,414 |
| Depreciation Amortization | 420 | 3,129 | 2,653 | 1,998 | 1,090 |
| Accounts receivable | -2,495 | -9,616 | -5,871 | -5,006 | -4,962 |
| Accounts payable and accrued liabilities | 1,837 | -2,847 | -3,569 | -2,141 | -1,410 |
| Other Working Capital | -25,552 | -23,189 | -2,166 | -14,753 | -3,991 |
| Other Operating Activity | 7,992 | 49,495 | 39,170 | 22,262 | 13,799 |
| Operating Cash Flow | $-59,197 | $-107,116 | $-132,591 | $-108,636 | $-52,888 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79 | -212 | -5 | N/A | N/A |
| Purchase Of Investment | -35,540 | -45,228 | -45,228 | -34,732 | -25,764 |
| Sale Of Investment | 21,584 | 192,780 | 162,303 | 124,376 | 68,950 |
| Other Investing Activity | 0 | -5,500 | -6,000 | 0 | 0 |
| Investing Cash Flow | $-14,035 | $141,840 | $111,070 | $89,644 | $43,186 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,783 | 13,648 | 12,752 | 12,736 | 10,676 |
| Other Financing Activity | 0 | 60,000 | 60,000 | 60,000 | 0 |
| Financing Cash Flow | $30,783 | $73,648 | $72,752 | $72,736 | $10,676 |
| Exchange Rate Effect | -90 | -48 | 87 | -155 | -91 |
| Beginning Cash Position | 197,445 | 89,121 | 89,121 | 89,121 | 89,121 |
| End Cash Position | 154,906 | 197,445 | 140,439 | 142,710 | 90,004 |
| Net Cash Flow | $-42,539 | $108,324 | $51,318 | $53,589 | $883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,197 | -107,116 | -132,591 | -108,636 | -52,888 |
| Capital Expenditure | -79 | -212 | -5 | N/A | N/A |
| Free Cash Flow | -59,276 | -107,328 | -132,596 | -108,636 | -52,888 |